Firm Analyst
Chardan Keay Nakae

Sonnet BioTherapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Sonnet BioTherapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Sonnet BioTherapeutics, Inc. or its management. Sonnet BioTherapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.